Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 12, Number 3—March 2006

Research

West Nile Virus Infections Projected from Blood Donor Screening Data, United States, 2003

Michael P. Busch*†Comments to Author , David J. Wright‡, Brian Custer*, Leslie H. Tobler*, Susan L. Stramer§, Steven H. Kleinman*‡¶, Harry E. Prince#, Celso Bianco**, Gregory Foster§, Lyle R. Petersen††, George Nemo‡‡, and Simone A. Glynn‡
Author affiliations: *Blood Systems Research Institute, San Francisco, California, USA; †University of California, San Francisco, California, USA; ‡Westat, Rockville, Maryland, USA; §American Red Cross National Testing and Reference Laboratories, Gaithersburg, Maryland, USA; ¶University of British Columbia, Victoria, British Columbia, Canada; #Focus Diagnostics, Cypress, California, USA; **America's Blood Centers, Washington DC, USA; ††Centers for Disease Control and Prevention, Fort Collins, Colorado, USA; ‡‡National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA

Main Article

Figure 5

Projected proportion of each state's population infected with West Nile virus versus the proportion of the state's population reporting neuroinvasive disease cases to the Centers for Disease Control and Prevention's ArboNET program. Data are excluded for 13 states: 6 states with neither minipool–nucleic acid amplification testing (MP-NAP) yield nor neuroinvasive cases, 6 states with 2 to 12 neuroinvasive cases but no MP-NAT yield, and 1 state with 1 MP-NAT–positive donor but no reported neuroinv

Figure 5. Projected proportion of each state's population infected with West Nile virus versus the proportion of the state's population reporting neuroinvasive disease cases to the Centers for Disease Control and Prevention's ArboNET program. Data are excluded for 13 states: 6 states with neither minipool–nucleic acid amplification testing (MP-NAP) yield nor neuroinvasive cases, 6 states with 2 to 12 neuroinvasive cases but no MP-NAT yield, and 1 state with 1 MP-NAT–positive donor but no reported neuroinvasive cases.

Main Article

TOP